Outsourcing provides a platform for establishing strategic collaborations, which eventually helps players to augment their expertise in this domain, through access to lucrative and innovative cost cutting peptide synthesis technologies offered by CMOs. We believe that, as more peptide drug candidates progress into late stage clinical trials, stakeholders are likely to depend more on CMOs for scaling up of their development and manufacturing processes. Moreover, given the success of certain blockbuster peptide drugs that are near patent expiry, such as (in alphabetical order) Lupron Depot, OZEMPIC and Victoza, a number of biosimilars are anticipated to enter the market in the near future. This is further likely to translate into a higher demand for contract development and manufacturing services.
The global overall peptide contract manufacturing market is estimated to be worth USD 3.9 billion by 2025, and this value is projected to reach USD 6.5 billion by 2030, growing at a CAGR of 15.8%, during the period 2020-2030. The outsourced component of the peptide API manufacturing market is likely to be worth USD 3.2 billion by 2030, growing at a CAGR of 11.2%, during the aforementioned time period. Whereas, the outsourced component of the peptide FDF manufacturing market is likely to be worth USD 2.5 billion by 2030, growing at a CAGR of 10.5%, during the aforementioned time period.
Presently, chemical method is preferred by CMOs for the manufacturing of peptide APIs and this trend is unlikely to change in the foreseen future. The contract manufacturing market for peptide APIs synthesized using liquid phase synthesis methods growing at a CAGR of 10.3%, whereas solid phase synthesis is likely to grow at a CAGR of 12.8%. On the other hand, the market for CMOs manufacturing peptide APIs using non-chemical / recombinant methods is expected to witness significant growth in the coming years as well.
The peptide API contract manufacturing market for large and very large companies / end-users is likely to be worth USD 2.2 billion by 2030, growing at a CAGR of 10.4%, during the period 2020-2030. On the other hand, as per the base case scenario of our forecast model, the share of mid-sized companies / end-users are likely to be worth USD 0.42 billion by 2030, growing at an annualized rate of 9.1%, during the period 2020-2030.
The peptide API contract manufacturing markets in Europe and North America are likely to grow at a CAGR of 12.1% and 10.3%, respectively. The higher growth rate of the European market can be attributed to the larger share of expansion initiatives that are being carried out in this region. For instance, in October 2019, Pepscan announced its plans to double its production capacity for therapeutic peptides and personalized peptide medicines at its Netherlands facility and in October 2017, CordenPharma announced an investment of USD 4.2 million for the expansion of its facility and upgradation of analytical equipment at its Germany facility. On the other hand, emerging markets within Asia Pacific and RoW are estimated to grow at an annualized rate of 11.4%. It is worth noting that North America has emerged as the current contract manufacturing hub for peptide therapeutics; further, the contract service revenues generated within the aforementioned region are estimated to be worth USD 1.1 billion by 2030. In addition, the peptide API contract manufacturing markets in Europe, and Asia Pacific and RoW are likely to be worth USD 1.0 billion and USD 1.1 billion by 2030, respectively.
The latest trending report Global Pharma & Cosmetics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The Pharma & Cosmetics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.The global Pharma & Cosmetics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 1882410 million by 2025, from USD 1662270 million in 2019.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/27438-pharma-and-cosmetics-market-analysis-reportThe major players covered in Pharma & Cosmetics are:Johnson & JohnsonBayerPfizerRocheGSKNovartisL' OREALEli LillySanofiMerck & CoShiseidoShanghai JahwaUnileverBeiersdorfKaoProcter & GambleHenkelEstee LauderBy Type, Pharma & Cosmetics market has been segmented intoOintmentsCreamsGelsOthersBy Application, Pharma & Cosmetics has been segmented into:PharmaceuticalsOTCCosmeticsThe report offers in-depth assessment of the growth and other aspects of the Pharma & Cosmetics market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.
)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Pharma & Cosmetics Market @ https://www.decisiondatabases.com/contact/download-sample-27438The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Pharma & Cosmetics product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Pharma & Cosmetics, with price, sales, revenue and global market share of Pharma & Cosmetics in 2018 and 2019.Chapter 3, the Pharma & Cosmetics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Pharma & Cosmetics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Pharma & Cosmetics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Pharma & Cosmetics sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Pharma & Cosmetics Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-27438Other Reports by DecisionDatabases.com:Global Anti Acne Cosmetics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Global Eye Cosmetic Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Global Colour Cosmetic Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
